ACT Stock Chart & Stats
CHF147.32
CHF0.00(0.00%)
―
--
Day’s Range― - ―
52-Week RangeCHF147.32 - CHF155.94
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
CHF1.55B
Enterprise ValueCHF1.78K
Total Cash (Recent Filing)CHF65.69M
Total Debt (Recent Filing)CHF90.22M
Price to Earnings (P/E)24.5
Beta0.62
Next Earnings
Oct 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.70
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio1.35
Price to Book (P/B)6.11
Price to Sales (P/S)2.79
P/FCF Ratio39.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF203.05Price Target Upside― Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)6.1
Revenue Forecast (FY)CHF569.90M
Bulls Say, Bears Say
Bulls Say
Specialty Chemicals Growth And MarginsThe specialty portfolio is becoming a larger share of sales while delivering strong margins, supported by favorable mix, higher volumes and high utilization. This mix shift can improve earnings quality and provide resilience beyond cyclical basic chemicals.
Reaffirmed Earnings OutlookMaintaining guidance after first-half sales and EBITDA growth indicates confidence in underlying demand and execution. Expected growth provides a durable earnings framework, even though quarterly results may fluctuate because of timing and project costs.
Capacity Expansion And Strategic GrowthNew capacity expands AlzChem’s ability to serve specialty applications and supports long-term volume growth. German commissioning offers nearer-term potential, while the U.S. project could broaden geographic reach and add meaningful future revenue.
Bears Say
Volatile Free Cash Flow And Higher DebtThe gap between operating cash flow and free cash flow indicates substantial investment or working-capital demands. Combined with higher debt, this can reduce financial flexibility and increase sensitivity to weaker margins or delayed project returns.
Agriculture And Fertilizer Market WeaknessWeak farm economics and structural cost disadvantages can keep fertilizer demand and profitability under pressure beyond one quarter. This limits the contribution of a cyclical business area while the group relies more heavily on specialty chemicals.
Refurbishment, Ramp-up And Input-cost PressureMaintenance outages and new-facility ramp-up costs will weigh on near-term profitability and may delay the benefits of added capacity. If energy or raw-material increases cannot be fully passed through, margins could remain pressured after the outage.
AlzChem Group AG News
ACT FAQ
What was AlzChem Group AG’s price range in the past 12 months?
AlzChem Group AG lowest stock price was CHF147.32 and its highest was CHF155.94 in the past 12 months.
What is AlzChem Group AG’s market cap?
AlzChem Group AG’s market cap is CHF1.55B.
When is AlzChem Group AG’s upcoming earnings report date?
AlzChem Group AG’s upcoming earnings report date is Oct 29, 2026 which is in 61 days.
How were AlzChem Group AG’s earnings last quarter?
AlzChem Group AG released its earnings results on Jul 30, 2026. The company reported CHF1.556 earnings per share for the quarter, the consensus estimate of CHF1.556 by CHF0.
Is AlzChem Group AG overvalued?
According to Wall Street analysts AlzChem Group AG’s price is currently Undervalued.
Does AlzChem Group AG pay dividends?
AlzChem Group AG does not currently pay dividends.
What is AlzChem Group AG’s EPS estimate?
AlzChem Group AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AlzChem Group AG have?
Currently, no data Available
What happened to AlzChem Group AG’s price movement after its last earnings report?
AlzChem Group AG reported an EPS of CHF1.556 in its last earnings report, expectations of CHF1.556. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of AlzChem Group AG?
Currently, no hedge funds are holding shares in CH:ACT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AlzChem Group AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF203.05 (― Upside)
CHF203.05 (― Upside)
Insider Transactions
Bought Shares
Worth CHF1.7M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
158.64%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
21.91%
Trailing 12-Months
Company Description
AlzChem Group AG
AlzChem Group AG operates globally, engaging in the development, production, and distribution of a wide array of chemical products through its subsidiaries. The company's reach extends across Germany, the European Union, the rest of Europe, Asia, the NAFTA region, and other international markets. Its business is organized into three primary divisions: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The diverse product portfolio includes prominent dietary supplements such as Creapure® and Alipure®, along with the creatine-based LIVADUR®. For animal nutrition, AlzChem supplies Creamino®, a guanidinoacetic acid preparation. The pharmaceutical industry benefits from its Bioselect® brand. Industrial applications feature DYHARD® curing agents, acting as accelerators in adhesives, powder coatings, printed circuit boards, and composites, while SILZOT® silicon nitride is vital for ceramics, electronics, and solar technology. The company also manufactures a variety of fine and foundational chemicals, encompassing products derived from calcium carbide, calcium cyanamide (marketed as PERLKA®), hydrogen cyanamide, dicyandiamide, guanidine, guanamines, nitroguanidine, and various aromatic and aliphatic nitriles. Its agricultural offerings include ALZOGUR® germicide for pig pens, Dormex® and Sitofex® plant growth regulators, and BREAK-THRU® plant protection additives. Furthermore, AlzChem provides crucial products for hot metal desulfurization and secondary metallurgy, in addition to technical gases. Beyond its core chemical activities, the group also oversees chemical park operations, offers administrative assistance, and delivers a range of infrastructure services. Established in 1908, AlzChem Group AG maintains its headquarters in Trostberg, Germany.